Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
c-KIT
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
106
212
318
424
530
636
742
848
954
1060
AiTan
(rivoceranib) / HLB Bio Group
sorafenib
/ Generic mfg.
imatinib
/ Generic mfg.
Focus V
(anlotinib) / Advenchen, Sino Biopharm
sunitinib
/ Generic mfg.
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
dasatinib
/ Generic mfg.
Stivarga
(regorafenib) / Bayer
Votrient
(pazopanib) / Novartis, BeiGene
Cabometyx
(cabozantinib tablet) / Exelixis, Ipsen
Tasigna
(nilotinib) / Novartis, Inhibikase
Iclusig
(ponatinib) / Takeda, Otsuka
Cometriq
(cabozantinib capsule) / Exelixis, Ipsen
Turalio
(pexidartinib) / Daiichi Sankyo
Nailike
(olverembatinib) / Ascentage Pharma, Takeda
Ayvakit
(avapritinib) / Blueprint Medicines
Hansoh Xinfu
(flumatinib) / Jiangsu Hengrui Pharma, Jiangsu Hansoh Pharma
